-
公开(公告)号:US20090258016A1
公开(公告)日:2009-10-15
申请号:US12455798
申请日:2009-06-05
申请人: Weibo Wang , Paul A. Barsanti , Yia Xia , Rustum Boyce , Sabina Pecchi , Nathan Brammeier , Megan C. Phillips , Kris Mendenhall , Kelly Wayman , Liana Marie Lagniton , Ryan Constantine , Hong Yang , Elizabeth Mieuli , Savithri Ramurthy , Elisa Jazan , Anu Sharma , Rama Jain , Sharadha Subramanian , Paul A. Renhowe , Kenneth W. Bair , David Duhl , Annette Walter , Tinya Abrams , Kay Huh , Eric Martin , Mark Knapp , Vincent P. Le
发明人: Weibo Wang , Paul A. Barsanti , Yia Xia , Rustum Boyce , Sabina Pecchi , Nathan Brammeier , Megan C. Phillips , Kris Mendenhall , Kelly Wayman , Liana Marie Lagniton , Ryan Constantine , Hong Yang , Elizabeth Mieuli , Savithri Ramurthy , Elisa Jazan , Anu Sharma , Rama Jain , Sharadha Subramanian , Paul A. Renhowe , Kenneth W. Bair , David Duhl , Annette Walter , Tinya Abrams , Kay Huh , Eric Martin , Mark Knapp , Vincent P. Le
IPC分类号: A61K39/395 , A61K31/4178 , A61K31/427 , A61K31/5386 , A61K31/4174 , A61P35/00
CPC分类号: C07D233/54 , C07D233/24 , C07D233/64 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/06 , C07D405/12 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/12 , C07D417/14 , C07D498/10
摘要: The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
摘要翻译: 本发明涉及新的取代的咪唑化合物及其药学上可接受的盐,酯或前药,新化合物的组合物和药学上可接受的载体,以及新化合物的用途。 本发明的化合物具有以下通式:
-
公开(公告)号:US07932262B2
公开(公告)日:2011-04-26
申请号:US12295967
申请日:2007-04-05
申请人: Savithri Ramurthy , Xiaodong Lin , Sharadha Subramanian , Alice Rico , Xiaojong M. Wang , Rama Jain , Jeremy M. Murray , Stephen E. Basham , Robert L. Warne , Wei Shu , Yasheen Zhou , Jeffrey Dove , Mina Aikawa , Payman Amiri , Weibo Wang , Johanna M. Jansen , Allan S. Wagman , Keith B. Pfister , Simon Ng
发明人: Savithri Ramurthy , Xiaodong Lin , Sharadha Subramanian , Alice Rico , Xiaojong M. Wang , Rama Jain , Jeremy M. Murray , Stephen E. Basham , Robert L. Warne , Wei Shu , Yasheen Zhou , Jeffrey Dove , Mina Aikawa , Payman Amiri , Weibo Wang , Johanna M. Jansen , Allan S. Wagman , Keith B. Pfister , Simon Ng
IPC分类号: A61K31/517
CPC分类号: C07D239/94 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/10 , C07D403/12 , C07D403/14 , C07D405/04 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/14 , C07D451/06 , C07D453/02
摘要: The invention provides quinazoline compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.
摘要翻译: 本发明提供作为PDK1抑制剂的喹唑啉化合物。 还提供了包含该化合物的药物组合物,以及用化合物或组合物治疗增殖性疾病如癌症的方法。
-
公开(公告)号:US20100048561A1
公开(公告)日:2010-02-25
申请号:US12295967
申请日:2007-04-05
申请人: Savithri Ramurthy , Xiaodong Lin , Sharadha Subramanian , Alice C. Rico , Xiaojing M. Wang , Rama Jain , Jeremy M. Murray , Steven E. Basham , Robert L. Warne , Wei Shu , Yasheen Zhou , Jeffrey Dove , Mina Aikawa , Payman Amiri , Weibo Wang , Johanna M. Jansen , Allan S. Wagman , Keith B. Pfister , Simon Ng
发明人: Savithri Ramurthy , Xiaodong Lin , Sharadha Subramanian , Alice C. Rico , Xiaojing M. Wang , Rama Jain , Jeremy M. Murray , Steven E. Basham , Robert L. Warne , Wei Shu , Yasheen Zhou , Jeffrey Dove , Mina Aikawa , Payman Amiri , Weibo Wang , Johanna M. Jansen , Allan S. Wagman , Keith B. Pfister , Simon Ng
IPC分类号: A61K31/517 , C07D401/12 , C07D401/14 , C07D239/84 , C07D413/14 , A61K31/5377 , A61P35/00
CPC分类号: C07D239/94 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/10 , C07D403/12 , C07D403/14 , C07D405/04 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/14 , C07D451/06 , C07D453/02
摘要: The invention provides quinazoline compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.
摘要翻译: 本发明提供作为PDK1抑制剂的喹唑啉化合物。 还提供了包含该化合物的药物组合物,以及用化合物或组合物治疗增殖性疾病如癌症的方法。
-
公开(公告)号:US07626040B2
公开(公告)日:2009-12-01
申请号:US11502303
申请日:2006-08-09
申请人: Paul A. Barsanti , Yi Xia , Weibo Wang , Kris G. Mendenhall , Liana M. Lagniton , Savithri Ramurthy , Megan C. Phillips , Sharadha Subramanian , Rustum Boyce , Nathan M. Brammeier , Ryan Constantine , David Duhl , Annette O. Walter , Tinya J. Abrams , Paul A. Renhowe
发明人: Paul A. Barsanti , Yi Xia , Weibo Wang , Kris G. Mendenhall , Liana M. Lagniton , Savithri Ramurthy , Megan C. Phillips , Sharadha Subramanian , Rustum Boyce , Nathan M. Brammeier , Ryan Constantine , David Duhl , Annette O. Walter , Tinya J. Abrams , Paul A. Renhowe
IPC分类号: C07D233/64 , C07D401/12 , C07D279/12 , C07D413/12 , C07D403/12
CPC分类号: C07D401/14 , C07D233/64 , C07D401/12 , C07D403/06 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12
摘要: The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses of the compounds. The compounds of the invention have the following general formula:
摘要翻译: 本发明涉及新的取代的咪唑化合物及其药学上可接受的盐,酯或前药,衍生物的组合物和药学上可接受的载体,以及该化合物的用途。 本发明的化合物具有以下通式:
-
公开(公告)号:US20070037853A1
公开(公告)日:2007-02-15
申请号:US11502303
申请日:2006-08-09
申请人: Paul Barsanti , Yi Xia , Weibo Wang , Kris Mendenhall , Liana Lagniton , Savithri Ramurthy , Megan Phillips , Sharadha Subramanian , Rustum Boyce , Nathan Brammeier , Ryan Constantine , David Duhl , Annette Walter , Tinya Abrams , Paul Renhowe
发明人: Paul Barsanti , Yi Xia , Weibo Wang , Kris Mendenhall , Liana Lagniton , Savithri Ramurthy , Megan Phillips , Sharadha Subramanian , Rustum Boyce , Nathan Brammeier , Ryan Constantine , David Duhl , Annette Walter , Tinya Abrams , Paul Renhowe
IPC分类号: A61K31/454 , A61K31/4439 , A61K31/42 , A61K31/4178 , A61K31/4172 , C07D413/02 , C07D403/02 , C07D409/02
CPC分类号: C07D401/14 , C07D233/64 , C07D401/12 , C07D403/06 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12
摘要: The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses of the compounds. The compounds of the invention have the following general formula:
摘要翻译: 本发明涉及新的取代的咪唑化合物及其药学上可接受的盐,酯或前药,衍生物的组合物和药学上可接受的载体,以及该化合物的用途。 本发明的化合物具有以下通式:
-
公开(公告)号:US20090285849A1
公开(公告)日:2009-11-19
申请号:US12380555
申请日:2009-02-26
申请人: Paul A. Barsanti , Nathan Brammeier , Anthony Diebes , Liana Marie Lagniton , Simon NG , Zhi Jie Ni , Keith B. Pfister , Casey Philbin , Nicholas Valiante , Allan S. Wagman , Weibo Wang , Amy J. Weiner
发明人: Paul A. Barsanti , Nathan Brammeier , Anthony Diebes , Liana Marie Lagniton , Simon NG , Zhi Jie Ni , Keith B. Pfister , Casey Philbin , Nicholas Valiante , Allan S. Wagman , Weibo Wang , Amy J. Weiner
IPC分类号: A61K39/385 , C07C337/08 , A61K31/175 , A61K31/495 , C07D295/112 , A61K39/00 , C07D413/12 , A61K31/5377 , A61P31/12 , A61P37/02
CPC分类号: C07D207/335 , A61K31/175 , A61K39/39 , A61K2039/55511 , C07D207/06 , C07D207/09 , C07D207/14 , C07D209/14 , C07D209/88 , C07D211/14 , C07D211/18 , C07D211/28 , C07D211/46 , C07D211/56 , C07D211/58 , C07D213/38 , C07D213/40 , C07D213/53 , C07D213/74 , C07D215/12 , C07D217/04 , C07D231/12 , C07D233/24 , C07D235/14 , C07D239/48 , C07D241/04 , C07D241/08 , C07D243/08 , C07D277/28 , C07D277/42 , C07D295/096 , C07D295/135 , C07D295/15 , C07D295/155 , C07D295/192 , C07D307/14 , C07D307/52 , C07D307/54 , C07D307/66 , C07D307/79 , C07D307/81 , C07D317/58 , C07D333/68 , C07D401/04 , C07D401/10 , C07D401/12 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/04 , C07D409/12 , C07D471/04 , C07D487/04 , C07D487/08 , C07D497/04 , A61K2300/00
摘要: Novel immune potentiators, novel vaccine adjuvants, novel compounds and pharmaceutical compositions, as well as novel methods for treating viral infections, including HCV, by administering the compounds and compositions, and novel methods for modulating the immune response by administering the compounds and/or compositions.
摘要翻译: 新型免疫增强剂,新型疫苗佐剂,新化合物和药物组合物,以及通过施用化合物和组合物治疗病毒感染(包括HCV)的新方法,以及通过施用化合物和/或组合物调节免疫应答的新方法 。
-
公开(公告)号:US07521062B2
公开(公告)日:2009-04-21
申请号:US10748071
申请日:2003-12-29
申请人: Paul A. Barsanti , Nathan Brammeier , Anthony Diebes , Liana Marie Lagniton , Simon Ng , Zhi-Jie Ni , Keith B. Pfister , Casey Philbin , Nicholas Valiante , Allan S. Wagman , Weibo Wang , Amy J. Weiner
发明人: Paul A. Barsanti , Nathan Brammeier , Anthony Diebes , Liana Marie Lagniton , Simon Ng , Zhi-Jie Ni , Keith B. Pfister , Casey Philbin , Nicholas Valiante , Allan S. Wagman , Weibo Wang , Amy J. Weiner
IPC分类号: A61K39/00 , A61K31/40 , A61K31/44 , A61K31/175 , A61K39/095 , A61K45/00
CPC分类号: C07D207/335 , A61K31/175 , A61K39/39 , A61K2039/55511 , C07D207/06 , C07D207/09 , C07D207/14 , C07D209/14 , C07D209/88 , C07D211/14 , C07D211/18 , C07D211/28 , C07D211/46 , C07D211/56 , C07D211/58 , C07D213/38 , C07D213/40 , C07D213/53 , C07D213/74 , C07D215/12 , C07D217/04 , C07D231/12 , C07D233/24 , C07D235/14 , C07D239/48 , C07D241/04 , C07D241/08 , C07D243/08 , C07D277/28 , C07D277/42 , C07D295/096 , C07D295/135 , C07D295/15 , C07D295/155 , C07D295/192 , C07D307/14 , C07D307/52 , C07D307/54 , C07D307/66 , C07D307/79 , C07D307/81 , C07D317/58 , C07D333/68 , C07D401/04 , C07D401/10 , C07D401/12 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/04 , C07D409/12 , C07D471/04 , C07D487/04 , C07D487/08 , C07D497/04 , A61K2300/00
摘要: The present invention is directed to novel immune potentiators, novel vaccine adjuvants, novel compounds and pharmaceutical compositions, novel methods for treating viral infections, including HCV, by administering the compounds, and novel methods for modulating an immune response by administering the compounds.
摘要翻译: 本发明涉及新型免疫增强剂,新型疫苗佐剂,新化合物和药物组合物,通过施用化合物治疗病毒感染(包括HCV)的新方法,以及通过施用化合物调节免疫应答的新方法。
-
公开(公告)号:US20100261679A1
公开(公告)日:2010-10-14
申请号:US12738277
申请日:2008-10-16
申请人: James Sutton , Martin Sendzik , Weibo Wang
发明人: James Sutton , Martin Sendzik , Weibo Wang
IPC分类号: A61K31/66 , C12N5/071 , A61K31/4709 , A61K31/517 , A61K31/5377 , A61K31/4439 , C07D215/38 , C07D401/12 , C07D413/12 , C07D417/10 , A61P35/00
CPC分类号: A61K31/4184 , A61K31/4188 , A61K31/428 , A61K31/429 , A61K31/47 , A61K31/517
摘要: Disclosed herein are compounds and their oxides, esters, prodrugs, solvates, and pharmaceutically acceptable salts thereof, compositions of the compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier, and uses of the compounds, either alone or in combination with at least one additional therapeutic agent. The embodiments are useful for inhibiting cellular proliferation, inhibiting the growth and/or metathesis of tumors, treating or preventing cancer, treating or preventing degenerating bone diseases such as rheumatoid arthritis, and/or inhibiting molecules such as CSF-1R.
摘要翻译: 本文公开了化合物及其氧化物,酯,前药,溶剂化物和药学上可接受的盐,化合物的组合物,单独或与至少一种另外的治疗剂组合与药学上可接受的载体,以及该化合物的用途, 单独或与至少一种另外的治疗剂组合。 这些实施方案可用于抑制细胞增殖,抑制肿瘤的生长和/或复分解,治疗或预防癌症,治疗或预防退行性骨疾病如类风湿性关节炎和/或抑制分子如CSF-1R。
-
公开(公告)号:US20050069555A1
公开(公告)日:2005-03-31
申请号:US10748071
申请日:2003-12-29
申请人: Paul Barsanti , Nathan Brammeier , Anthony Diebes , Liana Lagniton , Simon Ng , Zhi-Jie Ni , Keith Pfister , Casey Philbin , Nicholas Valiante , Allan Wagman , Weibo Wang , Amy Weiner
发明人: Paul Barsanti , Nathan Brammeier , Anthony Diebes , Liana Lagniton , Simon Ng , Zhi-Jie Ni , Keith Pfister , Casey Philbin , Nicholas Valiante , Allan Wagman , Weibo Wang , Amy Weiner
IPC分类号: A61K20060101 , A61K6/00 , A61K31/175 , A61K31/40 , A61K31/44 , A61K39/00 , A61K39/39 , A61P31/12 , C07D207/06 , C07D207/09 , C07D207/14 , C07D207/32 , C07D207/335 , C07D209/14 , C07D209/88 , C07D211/14 , C07D211/18 , C07D211/28 , C07D211/46 , C07D211/56 , C07D211/58 , C07D213/38 , C07D213/40 , C07D213/53 , C07D213/74 , C07D215/12 , C07D217/04 , C07D231/12 , C07D233/24 , C07D235/10 , C07D235/14 , C07D239/48 , C07D241/04 , C07D241/08 , C07D243/08 , C07D277/28 , C07D277/42 , C07D295/096 , C07D295/135 , C07D295/15 , C07D295/155 , C07D295/192 , C07D307/14 , C07D307/52 , C07D307/54 , C07D307/66 , C07D307/79 , C07D307/81 , C07D317/58 , C07D333/68 , C07D401/04 , C07D401/10 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/04 , C07D409/12 , C07D413/10 , C07D413/12 , C07D471/04 , C07D487/04 , C07D487/08 , C07D497/04
CPC分类号: C07D207/335 , A61K31/175 , A61K39/39 , A61K2039/55511 , C07D207/06 , C07D207/09 , C07D207/14 , C07D209/14 , C07D209/88 , C07D211/14 , C07D211/18 , C07D211/28 , C07D211/46 , C07D211/56 , C07D211/58 , C07D213/38 , C07D213/40 , C07D213/53 , C07D213/74 , C07D215/12 , C07D217/04 , C07D231/12 , C07D233/24 , C07D235/14 , C07D239/48 , C07D241/04 , C07D241/08 , C07D243/08 , C07D277/28 , C07D277/42 , C07D295/096 , C07D295/135 , C07D295/15 , C07D295/155 , C07D295/192 , C07D307/14 , C07D307/52 , C07D307/54 , C07D307/66 , C07D307/79 , C07D307/81 , C07D317/58 , C07D333/68 , C07D401/04 , C07D401/10 , C07D401/12 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/04 , C07D409/12 , C07D471/04 , C07D487/04 , C07D487/08 , C07D497/04 , A61K2300/00
摘要: The present invention is directed to novel immune potentiators, novel vaccine adjuvants, novel compounds and pharmaceutical compositions, novel methods for treating viral infections, including HCV, by administering the compounds, and novel methods for modulating an immune response by administering the compounds.
摘要翻译: 本发明涉及新型免疫增强剂,新型疫苗佐剂,新化合物和药物组合物,通过施用化合物治疗病毒感染(包括HCV)的新方法,以及通过施用化合物调节免疫应答的新方法。
-
公开(公告)号:US20080207589A1
公开(公告)日:2008-08-28
申请号:US11969164
申请日:2008-01-03
申请人: Rustum Boyce , Eric Martin , Weibo Wang , Hong Yang , Paul A. Barsanti
发明人: Rustum Boyce , Eric Martin , Weibo Wang , Hong Yang , Paul A. Barsanti
IPC分类号: A61K31/553 , C07D403/02 , C07D413/02 , A61K31/5377 , A61K31/422 , C12N9/99 , A61P35/00 , C12N5/00 , A61K31/4164 , A61K31/496 , A61K31/5513 , C07D233/61
CPC分类号: C07D403/06 , C07D413/06
摘要: The present invention relates to new substituted imidazole compounds have the following Formula (I) and to the pharmaceutically acceptable salts, esters, or prodrugs thereof, to compositions of the compounds together with pharmaceutically acceptable carriers, and to uses of the compounds:
摘要翻译: 本发明涉及具有下式(I)的新的取代咪唑化合物及其药学上可接受的盐,酯或前药与化合物与药学上可接受的载体的组合物,以及该化合物的用途:
-
-
-
-
-
-
-
-
-